Home

Life Sciences

Increasing regulatory and competitive pressures are combining to ensure that the global Life Science industry is entering a period of unprecedented change.  With the traditional industry business model becoming economically unsustainable (and the time-honoured solution of merging with like-size companies no longer likely to address the underlying threats to business performance), it is feasible that the largest pharmaceutical companies could see revenues decline significantly over the next few years. 

A fundamental re-think of the Life Science operating model is therefore required.  Smart Life Science companies are therefore looking at how to use this period of change as an opportunity to re-engineer their businesses in ways that can deliver sustainable improvements in performance.

Fortunately, the opportunities to develop strategic markets (diversifying into targeted innovative speciality products and new emerging territories, for example) and improve operational performance are many. 

Within the specific realm of operations, significant potential exists to reap substantial rewards by:

• Reducing the cost of R&D (whilst simultaneously boosting productivity of regulator-approved products)
• Improving the operational effectiveness of the manufacturing and supply chain network (by reducing over-capacity and substantially improving productivity at each stage of those value chains)
• Transforming commercial operations (by moving from a sales-rep dominated model to a more strategic and speciality focused sales organisation that operates on best Account Management principles)
• Streamlining key operations and processes (and generating employee buy-in) following M&A (merger and acquisition) activities so that significant operational synergy targets are actually realised.

UEP – Supporting Life Science Companies to Realise Significant Operational Efficiency Gains
UEP is supporting Life Science companies in their challenge to radically transform their business model and achieve exceptional levels of operational performance across many of the aforementioned areas – designing more efficient processes, improving productivity, reducing costs, and engaging with their people to transform, sustain and continuously improve their operating environment.

Our assignments consistently deliver exceptionally high Returns On Investment and rapid payback (as the sample case study illustrates), with these gains in turn releasing cash to fund the pursuit of further efficiency gains and the diversification of the business.

To learn more about how UEP is helping Life Science organisations to achieve sustained improvements in operational performance, please contact: 

Alan Evans
Mobile: 07884 234459
Email: alan.evans@unipart.co.uk

Ian Arbuthnott
Mobile: 07824 609004
Email: ian.arbuthnott@unipart.co.uk